149 related articles for article (PubMed ID: 9209495)
1. HTLV-I-infected T cells activate autologous CD4+ T cells susceptible to HTLV-I infection in a costimulatory molecule-dependent fashion.
Takamoto T; Makino M; Azuma M; Kanzaki T; Baba M; Sonoda S
Eur J Immunol; 1997 Jun; 27(6):1427-32. PubMed ID: 9209495
[TBL] [Abstract][Full Text] [Related]
2. Costimulatory effects of T cell proliferation during infection with human T lymphotropic virus types I and II are mediated through CD80 and CD86 ligands.
Lal RB; Rudolph DL; Dezzutti CS; Linsley PS; Prince HE
J Immunol; 1996 Aug; 157(3):1288-96. PubMed ID: 8757637
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+ T cells.
Wolthers KC; Otto SA; Lens SM; Kolbach DN; van Lier RA; Miedema F; Meyaard L
Eur J Immunol; 1996 Aug; 26(8):1700-6. PubMed ID: 8765009
[TBL] [Abstract][Full Text] [Related]
4. Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax.
Takatsuka N; Hasegawa A; Takamori A; Shimizu Y; Kato H; Ohashi T; Amagasa T; Masuda T; Kannagi M
Int Immunol; 2009 Sep; 21(9):1089-100. PubMed ID: 19654198
[TBL] [Abstract][Full Text] [Related]
5. Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cells.
Plumas J; Chaperot L; Jacob MC; Molens JP; Giroux C; Sotto JJ; Bensa JC
Eur J Immunol; 1995 Dec; 25(12):3332-41. PubMed ID: 8566020
[TBL] [Abstract][Full Text] [Related]
6. Human T lymphotropic virus-type I Tax induction of CD21/Epstein-Barr virus receptor expression on T cells and its significance in leukemogenesis of adult T cell leukemia.
Ohtsubo H; Arima N; Matsushita K; Hidaka S; Fujiwara H; Arimura K; Kukita T; Fukumori J; Matsumoto T; Eizuru Y; Tanaka H
Exp Hematol; 1997 Nov; 25(12):1246-52. PubMed ID: 9357968
[TBL] [Abstract][Full Text] [Related]
7. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
Satoh M; Toma H; Sugahara K; Etoh K; Shiroma Y; Kiyuna S; Takara M; Matsuoka M; Yamaguchi K; Nakada K; Fujita K; Kojima S; Hori E; Tanaka Y; Kamihira S; Sato Y; Watanabe T
Oncogene; 2002 Apr; 21(16):2466-75. PubMed ID: 11971181
[TBL] [Abstract][Full Text] [Related]
8. T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells.
Rondelli D; Anasetti C; Fortuna A; Ratta M; Arpinati M; Bandini G; Lemoli RM; Tura S
Bone Marrow Transplant; 1998 Jun; 21(12):1183-91. PubMed ID: 9674849
[TBL] [Abstract][Full Text] [Related]
9. Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen.
Subauste CS; de Waal Malefyt R; Fuh F
J Immunol; 1998 Feb; 160(4):1831-40. PubMed ID: 9469444
[TBL] [Abstract][Full Text] [Related]
10. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
Mukherjee S; Ahmed A; Nandi D
J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
[TBL] [Abstract][Full Text] [Related]
11. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes.
Frandji P; Tkaczyk C; Oskeritzian C; David B; Desaymard C; Mécheri S
Eur J Immunol; 1996 Oct; 26(10):2517-28. PubMed ID: 8898968
[TBL] [Abstract][Full Text] [Related]
12. Human fibroblasts transduced with CD80 or CD86 efficiently trans-costimulate CD4+ and CD8+ T lymphocytes in HLA-restricted reactions: implications for immune augmentation cancer therapy and autoimmunity.
Smythe JA; Fink PD; Logan GJ; Lees J; Rowe PB; Alexander IE
J Immunol; 1999 Sep; 163(6):3239-49. PubMed ID: 10477593
[TBL] [Abstract][Full Text] [Related]
13. Production of functionally deficient dendritic cells from HTLV-I-infected monocytes: implications for the dendritic cell defect in adult T cell leukemia.
Makino M; Wakamatsu S; Shimokubo S; Arima N; Baba M
Virology; 2000 Aug; 274(1):140-8. PubMed ID: 10936095
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in adult T-cell leukemia (ATL) in non-ATL-endemic Hokkaido of Japan.
Iwanaga M; Takada K; Fujiwara S; Oikawa O; Sugiura M; Imai S; Osato T; Mikuni C; Maekawa I; Miyazaki T
In Vivo; 1994; 8(6):1007-10. PubMed ID: 7772727
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4+ T cells depends on strength of the CD3 signal: critical role for IL-2.
Mukherjee S; Ahmed A; Malu S; Nandi D
J Leukoc Biol; 2006 Jul; 80(1):66-74. PubMed ID: 16624934
[TBL] [Abstract][Full Text] [Related]
16. Monocyte-driven activation-induced apoptotic cell death of human T-lymphotropic virus type I-infected T cells.
Wakamatsu S; Makino M; Tei C; Baba M
J Immunol; 1999 Oct; 163(7):3914-9. PubMed ID: 10490992
[TBL] [Abstract][Full Text] [Related]
17. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
18. Majority of interferon-gamma-producing CD4+ cells in patients infected with human T cell lymphotrophic virus do not express tax protein.
Mitre E; Thompson RW; Carvalho EM; Nutman TB; Neva FA
J Infect Dis; 2003 Aug; 188(3):428-32. PubMed ID: 12870125
[TBL] [Abstract][Full Text] [Related]
19. In vivo cellular tropism of human T-lymphotropic virus type II is not restricted to CD8+ cells.
Lal RB; Owen SM; Rudolph DL; Dawson C; Prince H
Virology; 1995 Jul; 210(2):441-7. PubMed ID: 7542419
[TBL] [Abstract][Full Text] [Related]
20. Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells.
Yssel H; de Waal Malefyt R; Duc Dodon MD; Blanchard D; Gazzolo L; de Vries JE; Spits H
J Immunol; 1989 Apr; 142(7):2279-89. PubMed ID: 2466894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
